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Abstract. A well described interaction between an anti-
bradycardia pacemaker and a ventricular de®brillator
is sensing of pacemaker stimuli by the ventricular
de®brillator. This report describes an interaction
between an atrial demand pacemaker and a ventricu-
lar de®brillator that resulted in ventricular asystole
and polymorphic ventricular tachycardia. In this case,
the ventricular de®brillator sensed atrial pacing
stimuli when complete atrioventricular block with a
slow ventricular escape rate developed. De®brillator-
based ventricular demand pacing was inhibited, result-
ing in prolonged periods of ventricular asystole,
polymorphic ventricular tachycardia, and multiple
de®brillator shocks. Ventricular de®brillator sensing
of atrial pacemaker stimuli in the setting of complete
atrioventricular block and ventricular asystole cannot
be simulated during de®brillator implantation when
atrioventricular conduction is intact. Therefore, a
pacemaker programmed to atrial demand pacing in a
patient with a ventricular de®brillator can result in
inappropriate inhibition of ventricular pacing in the
setting of complete heart block. Furthermore, this
interaction can be avoided with a dual-chamber
pacing ventricular de®brillator.




In the era of ventricular de®brillators with rate-
responsive dual-chamber pacing, implantation of
a single chamber ventricular de®brillator might
still be considered in a patient with a preexisting
rate-responsive pacemaker system or in a patient
in whom battery longevity is a critical issue.
Numerous adverse interactions in patients with
a pacemaker and a ventricular de®brillator have
been described [1±3]. This report describes an
interaction between an atrial demand pacemaker
and a ventricular de®brillator that occurred in a
patient in whom complete atrioventricular block
with prolonged periods of ventricular asystole
developed and resulted in sustained polymorphic
ventricular tachycardia.
Case Report
A 73 year old woman was admitted to an outside
hospital with a chief complaint of multiple ventric-
ular de®brillator discharges. The patient had a
past medical history of coronary artery disease,
myocardial infarction, diabetes mellitus, rheu-
matic disease of the mitral and tricuspid valves,
congestive heart failure, and a left ventricular
ejection fraction of 0.35. Eight years prior to
admission an epicardial ventricular de®brillator
system was implanted for syncope and ventricu-
lar tachycardia. Two weeks later, she developed
sinus bradycardia, long-short sequences, and
polymorphic ventricular tachycardia which
resulted in multiple de®brillator shocks. The
patient was treated with an atrial demand pace-
maker. Four years later, the ventricular de®bril-
lator and the pacemaker systems became infected
and were explanted. After an appropriate course
of antibiotic therapy, a de®brillator lead
(Guidant, St. Paul MN, model 0072) was posi-
tioned in the patient's right ventricular apex and
attached to a ventricular de®brillator pulse
generator (Guidant, model 1746). An atrial pace-
maker lead (Guidant, model 4269) was positioned
in the right atrial appendage and connected to a
bipolar SSI pacemaker pulse generator (Guidant,
model 446). Intraoperatively, sensing of the atrial
pacemaker stimulus by the ventricular de®bril-
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lator was observed at an amplitude of 3.75 V with
a pulse width of 0.4 ms. The atrial pacemaker
stimulus was not sensed at an amplitude of 2.5 V
and a pulse width of 0.6 ms. The ventricular
de®brillator sensed ventricular ®brillation when
the pacemaker was programmed to asynchronous
atrial pacing with an amplitude of 2.5 V and a
pulse width of 0.6 ms. The pacemaker was chroni-
cally programmed to the AAI mode with an
amplitude of 2.5 V and a pulse width of 0.6 ms.
Amiodarone at a daily dosage of 200 mg was
initiated subsequently for atrial ®brillation.
Interrogation of the patient's ventricular de®-
brillator upon presentation to the University of
Michigan Medical Center demonstrated 19
episodes of polymorphic ventricular tachycardia,
12 of which were sustained and resulted in
shocks. During AAI pacing at 85 beats per
minute, the patient developed complete atrioven-
tricular block (Fig. 1). The ventricular de®brilla-
tor sensed pacing stimuli from the atrial
pacemaker which inhibited VVI pacing. Long-
short sequences occurred, and polymorphic
ventricular tachycardia resulted. Normal post-
shock VVI pacing was observed (Fig. 1). However,
after non-sustained episodes of polymorphic
ventricular tachycardia with diverted shocks,
the ventricular de®brillator sensed the atrial
pacing stimuli, de®brillator-based VVI pacing
was inhibited, and ventricular asystole resulted
(Fig. 2).
Programmed settings for the atrial pacemaker
were AAI pacing at 85 beats per minute with
an output amplitude of 2.5 V with a pulse width
of 0.6 ms. The pacemaker was immediately de-
activated and the ventricular de®brillator's VVI
pacing rate was increased to 85 beats per minute.
Amiodarone, desethylamiodarone and digoxin
concentrations were 1.1 mg=ml, 0.9 mg=ml, and
1.7 ng=ml, respectively. Within hours of disconti-
nuing amiodarone and digoxin, atrioventricular
conduction resumed. The patient received a




Oversensing of atrial pacemaker stimuli by a
ventricular de®brillator, with subsequent inhibi-
tion of de®brillator-based VVI pacing in the
setting of atrioventricular block, has not been
Fig. 1. This intracardiac electrogram from the ventricular de®brillator demonstrates atrial pacing and capture (arrow) in the
setting of complete atrioventricular block. De®brillator-based VVI pacing is inhibited due to sensing of the atrial pacemaker stimuli
(*). A long-short sequence results in polymorphic ventricular tachycardia. A 17 joule shock terminated the tachycardia. Normal
post-shock de®brillator-based VVI pacing at 60 beats per minute occurs. (Note that ventricular paced beats have no visible pacing
artifacts.)
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described as a pacemaker±de®brillator interac-
tion.
Mechanism
The pacemaker±de®brillator interaction de-
scribed herein is most likely due to the de®b-
rillator's capability to automatically adjust
sensitivity. These sensing ampli®ers and algo-
rithms differ among different companies. In our
case, after a sensed event, the de®brillator auto-
matically adjusted the sensitivity to 75% of the
amplitude of the sensed signal. After the ventri-
cular refractory period, the sensitivity doubled
every 156 ms until either a signal was sensed or
the maximum sensitivity was reached. In this
patient, an atrial pacemaker stimulus was not
sensed by the de®brillator immediately after the
onset of complete atrioventricular block. Without
sensed ventricular events, the de®brillator's
sensitivity increased such that the next atrial
pacing stimulus was sensed. Since the ventricu-
lar escape interval was programmed to 1500 ms,
which was much longer than the atrial escape
interval of 706 ms, de®brillator-based ventricular
demand pacing was continuously inhibited. This
resulted in severe bradycardia and polymorphic
ventricular tachycardia. Post-shock VVI pacing,
in contrast, occurred with a ®xed sensitivity of
2.5 mV, which was inadequate for sensing atrial
pacing stimuli. However, after a nonsustained
episode of polymorphic ventricular tachycardia,
the sensitivity remained at maximum, the atrial
stimuli were sensed, and de®brillator-based VVI
pacing was inhibited.
Previous Studies
Numerous reports indicate that implantation of a
de®brillator and a separate pacemaker is safe if
intraoperative testing fails to demonstrate over-
sensing or undersensing [4±6]. For instance,
sensing of a pacemaker stimulus during ventric-
ular ®brillation may lead to inhibition of ventric-
ular ®brillation therapy [1]. Conversely, sensing
of the pacemaker stimulus and the associated
evoked potential may lead to inappropriate
shocks [7±9].
Fig. 2. An intracardiac electrogram showing a nonsustained episode of polymorphic ventricular tachycardia. The de®brillator
senses the atrial pacemaker stimuli (*), de®brillator-based VVI pacing is inhibited, long-short sequences occur, and nonsustained
polymorphic ventricular tachycardia results. Atrial pacing stimuli are sensed following the spontaneous termination of the
polymorphic ventricular tachycardia, de®brillator-based VVI pacing is inhibited, and ventricular asystole results.
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Clinical Implications
Based on this case report, previously described
pacemaker-de®brillator interactions can be safely
excluded during intraoperative testing only if the
pacemaker is programmed to a mode that incor-
porates ventricular sensing. As many as 12% of
patients with normal AV-conduction at the time
of AAI pacemaker implantation will develop
second or third degree AV block [10]. This
report highlights the potential for serious device
interactions in patients with a de®brillator and
pacemaker-based AAI pacing. This interaction
can be avoided with a dual-chamber pacing
ventricular de®brillator.
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